We’re excited to share our latest work on tumour microdialysis, a powerful technique for measuring unbound, pharmacologically active drug concentrations directly within brain tumours like glioblastoma. Unlike systemic plasma levels, microdialysis provides a true picture of drug penetration into the tumour helping to uncover heterogeneous distribution and the impact of the blood-tumour barrier. Our approach involves precise stereotaxic surgery, tumour validation, and sampling from both tumour and healthy brain tissue enabling direct, comparative pharmacokinetic analysis. 📊 The results? Significant differences in drug exposure between tumour core and surrounding tissue. 👉 Swipe through the carousel to explore our process and findings.  🔗 www.pharmidex.com

We’re excited that Ash Alavijeh (Head of Operations) and Ian Knowles (Head of Respiratory) will attend ON Helix 2025 on 3 July in Cambridge, UK .  They look forward to meeting fellow attendees and exploring new ways to collaborate in drug discovery and development . 📍 https://www.onhelix.com